IT Implementation Services for Pharmaceutical CustomerThe Customer The customer is a global pharmaceutical company with market leading positions in generic pharmaceuticals, trans-dermal technology and unit dose packaged products. It is a world leader in the research, development, production, and marketing of generic pharmaceuticals. The Business Challenge The customer’s core requirement was to have IT setup and services which would run the business, without compromising on service levels and system availability, thereby providing significant cost advantage Solution The model proposed by Zensar’s IT Program management services proved to be a very successful because of the economies of scale it provided. The approach towards the operational and functional requirements enabled the customer to ensure full satisfaction to their respective customers. Business Benefit - Cost benefits on a growing scale economy,sizable reduction on upfront investment, minimal overheads in maintaining skilled resources.
- Single point of contact for any IT infrastructure related concerns.
- Helpdesk and infrastructure support provided as per business requirements.
- Maximum system uptime as it leveraged facilities like:
Availability: - Follow the customer’s SOP to analyze and resolve availability issues on support systems .
- Ensure database integrity.
- Support system log monitoring and exception notification.
Resilience: - Perform regular backup log testing.
- Review support system’s resilience potential.
Performance: - High-level proactive performance monitoring to measure current performance.
- Reactive performance analysis.
- Create and communicate customer’s basic recommendations to overcome current and future performance.
Maintenance: - Perform trend analysis of space monitoring.
- Proactively analyze storage space utilization.
- Provide basic indicators of system “health” and high-level suggestions to future activities.
Scalability: - Basic system capacity assessment to indicate current system load across CPU, memory, disk and kernel.
|